JD Health's stock price soared 5.00% during intraday trading on Monday, reflecting strong investor sentiment.
The surge follows the announcement of a comprehensive strategic partnership between JD Health and leading domestic medical device brand Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. The companies have set an ambitious three-year sales target of RMB 10 billion, aiming to set a new industry benchmark for growth.
The collaboration will leverage JD Health's core capabilities in AI technology, digital services, supply chain management, and user operations to reshape medical devices through AI, with initial focus on blood glucose management and respiratory health. This includes developing AI-powered data analysis for diabetes management and integrating AI algorithms into ventilators for smart respiratory care.
Comments